Concord Drugs Ltd Q3 FY2025-2026 Results: Summary
Revenue | ₹16.99Cr |
Net Profits | ₹0.22Cr |
Net Profit Margins | 1.29% |
Concord Drugs Ltd’s revenue jumped 57.31% since last year same period to ₹16.99Cr in the Q3 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 65.27% jump in its revenue since last 3-months.
Concord Drugs Ltd’s net profit fell -4.35% since last year same period to ₹0.22Cr in the Q3 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated 15.79% jump in its net profits since last 3-months.
Concord Drugs Ltd’s net profit margin fell -39.2% since last year same period to 1.29% in the Q3 2025-2026. On a quarterly growth basis, Concord Drugs Ltd has generated -29.94% fall in its net profit margins since last 3-months.
FAQs
What was the revenue for Concord Drugs Ltd in Q3 results 2025?
The revenue for Concord Drugs Ltd in the Q3 results 2025 was ₹16.99Cr.
What was the net profit for Concord Drugs Ltd in Q3 results 2025?
The net profit for Concord Drugs Ltd in the Q3 results 2025 was ₹0.22Cr.
What was the net profit margin for Concord Drugs Ltd in Q3 results 2025?
The net profit margin for Concord Drugs Ltd in the Q3 results 2025 was 1.29%.
What was the revenue for Concord Drugs Ltd in Q3 results 2024?
The revenue for Concord Drugs Ltd in the Q3 results 2024 was ₹10.80Cr.
What was the net profit for Concord Drugs Ltd in Q3 results 2024?
The net profit for Concord Drugs Ltd in the Q3 results 2024 was ₹0.23Cr.
What was the net profit margin for Concord Drugs Ltd in Q3 results 2024?
The net profit margin for Concord Drugs Ltd in the Q3 results 2024 was 2.13%.
